selectivity Cancer Research Results

selectivity, selectivity: Click to Expand ⟱
Source:
Type:
The selectivity of cancer products (such as chemotherapeutic agents, targeted therapies, immunotherapies, and novel cancer drugs) refers to their ability to affect cancer cells preferentially over normal, healthy cells. High selectivity is important because it can lead to better patient outcomes by reducing side effects and minimizing damage to normal tissues.

Achieving high selectivity in cancer treatment is crucial for improving patient outcomes. It relies on pinpointing molecular differences between cancerous and normal cells, designing drugs or delivery systems that exploit these differences, and overcoming intrinsic challenges like tumor heterogeneity and resistance

Factors that affect selectivity:
1. Ability of Cancer cells to preferentially absorb a product/drug
-EPR-enhanced permeability and retention of cancer cells
-nanoparticle formations/carriers may target cancer cells over normal cells
-Liposomal formations. Also negatively/positively charged affects absorbtion

2. Product/drug effect may be different for normal vs cancer cells
- hypoxia
- transition metal content levels (iron/copper) change probability of fenton reaction.
- pH levels
- antiOxidant levels and defense levels

3. Bio-availability


Scientific Papers found: Click to Expand⟱
2185- SK,    Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
- in-vitro, Lung, LLC1 - in-vitro, Melanoma, B16-BL6 - in-vivo, NA, NA
Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, selectivity↑, Warburg↓, TumVol↓, TumW↓,
2227- SK,    Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species
- in-vitro, GC, BGC-823 - in-vitro, GC, SGC-7901 - in-vitro, Nor, GES-1
selectivity↑, TumCP↓, TumCD↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, Endon↑, AIF↑, eff↓, ChemoSen↑, TumCCA↑, GSH/GSSG↓, lipid-P↑,
2226- SK,    Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma
- in-vitro, HCC, HUH7 - in-vitro, HCC, Bel-7402
selectivity↑, ROS↑, eff↓, Akt↓, RIP1↓, NF-kB↓,
3048- SK,    Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, 4T1 - in-vitro, Nor, MCF12A - in-vivo, NA, NA
tumCV↓, selectivity↑, EMT↓, TumCMig↓, TumCI↓, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, β-catenin/ZEB1↓, GSK‐3β↑,
2008- SK,  Cisplatin,    Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
- in-vitro, CRC, HCT116 - in-vivo, NA, NA
ChemoSen↑, selectivity↑, i-ROS↑, DNAdam↑, MMP↓, TumCCA↑, eff↓, *toxicity↓,
2010- SK,    Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
- in-vitro, Lung, H1975 - in-vitro, Lung, H1650 - in-vitro, Nor, CCD19
EGFR↓, selectivity↑, Casp↑, PARP↑, Apoptosis↑, ROS↑, eff↓, selectivity↑,
2007- SK,    Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
- in-vitro, lymphoma, U937 - in-vitro, BC, MCF7 - in-vitro, BC, SkBr3 - in-vitro, CRC, HCT116 - in-vitro, OS, U2OS - NA, Nor, RPE-1
tumCV↓, selectivity↑, Dose↝, other↑, MMP↓, ROS↑, DNAdam↑, Ca+2↑, Casp9↑, Cyt‑c↑, *toxicity↓,
2009- SK,    Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer
- in-vitro, Bladder, NA
TumCG↓, selectivity↑, *toxicity∅, Necroptosis↑, ROS↑, p62↑, Keap1↑, *NRF2↑, Synergy↑,
1688- SSE,    Potential Role of Selenium in the Treatment of Cancer and Viral Infections
- Review, Var, NA
IL2↑, INF-γ↑, Th1 response↑, Th2↑, Dose↑, AntiCan∅, Risk↑, chemoP↑, Hif1a↓, VEGF↓, selectivity↑, *GADD45A↑, NRF2↓, *NRF2↑, ChemoSen↑, angioG↓, PrxI↓, ChemoSideEff↓, Synergy↑,
5078- SSE,  Rad,    Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer
- Trial, Pca, NA
Half-Life↝, OS↑, Pain↓, PSA↓, GSH↓, ROS↑, selectivity↑, TumCG↓, AR↓, Dose↑, ChemoSen↑, RadioS↑,
5074- SSE,    Application of Sodium Selenite in the Prevention and Treatment of Cancers
- Review, Var, NA
Imm↑, angioG↑, DNArepair↑, NK cell↑, ROS↑, AntiCan↑, selectivity↑, ER Stress↑, TumAuto↑, necrosis↑, toxicity↝, Dose↑,
5093- SSE,    Pharmacological mechanisms of the anticancer action of sodium selenite against peritoneal cancer in mice
- in-vivo, Var, NA
AntiCan↑, eff↑, selectivity↑, ROS↑, Dose↝, Trx↓, GSH↓,
5110- SSE,    Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells
- in-vitro, AML, APL NB4
Apoptosis↑, selectivity↑, TumAuto↓, PI3K↓, Akt↓,
5088- SSE,    Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite
- in-vitro, BC, MCF7 - in-vitro, GBM, U87MG - in-vitro, Pca, PC3 - in-vitro, Cerv, HeLa - in-vitro, GBM, A172
Ferroptosis↑, ROS↑, Iron↑, xCT/SLC7A11↓, GSH↓, GPx4↓, lipid-P↑, TumCP↓, selectivity↑,
5086- SSE,    Sodium Selenite Induces Superoxide-Mediated Mitochondrial Damage and Subsequent Autophagic Cell Death in Malignant Glioma Cells
- in-vitro, GBM, U87MG - in-vitro, GBM, T98G - in-vitro, GBM, A172
TumAuto↑, ROS↑, TumCD↑, tumCV↓, selectivity↑, MMP↓, eff↓, MitoP↑,
4742- SSE,    Antitumor Effects of Selenium
- Review, Var, NA - Review, Arthritis, NA - Review, Sepsis, NA
*antiOx↓, *Inflam↓, Risk↓, TumCI↓, TumMeta↓, radioP↑, chemoP↑, Apoptosis↑, ROS↑, DNAdam↑, Dose↑, selectivity↑, *other↓, *BioAv↑, ROS↑, MMP↓, Casp↑, *Imm↑, *Pain↓, Sepsis↓, MMP2↓, MMP9↓, *Half-Life↓,
6438- T4O,    Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species
- in-vitro, CRC, HCT116
mt-ROS↑, TumCP↑, tumCV↑, eff↓, TumVol↓, selectivity↑,
6436- T4O,    Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expression
- in-vitro, Melanoma, A431
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, EMT↓, AntiTum↑, cal2↑, cl‑β-catenin/ZEB1↑, cl‑Casp12↑, Bcl-2↓, cycD1/CCND1↓, CDK2↓, BAX↑, TumCCA↑, selectivity↑, N-cadherin↓, E-cadherin↑, Ki-67↓, PCNA↑,
6435- T4O,    Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models
- in-vitro, Melanoma, NA
selectivity↑, Apoptosis↑, Synergy↑, ChemoSen↑, BioAv↝,
6432- T4O,    Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species
- in-vitro, CRC, HCT116
other↝, Apoptosis↑, mt-ROS↑, eff↓, tumCV↓, TumCP↓, selectivity↑, TumCG↓,
5327- TFdiG,    Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells
- in-vitro, Ovarian, A2780S
TumCG↓, selectivity↑, TumCCA↑, Apoptosis↑, P53↑, BAX↑, BAD↑, cl‑Casp3↑, p‑Akt↓, MDM2↓, MMP↓, Cyt‑c↑,
5330- TFdiG,  Cisplatin,    Theaflavin-3,3′-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells
- in-vitro, Ovarian, A2780S - in-vitro, Ovarian, OVCAR-3
selectivity↑, ChemoSen↑, DNAdam↑, GSH↓, CTR1↑,
1935- TQ,    Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
- Review, OS, NA
Apoptosis↑, TumCCA↑, angioG↓, TumMeta↓, ROS↑, P53↑, Twist↓, E-cadherin↑, N-cadherin↓, NF-kB↓, IL8↓, XIAP↓, Bcl-2↓, STAT3↓, MAPK↓, PI3K↓, Akt↓, ERK↓, MMP2↓, MMP9↓, *ROS↓, HO-1↑, selectivity↑, TumCG↓,
1936- TQ,    Thymoquinone induces apoptosis and increase ROS in ovarian cancer cell line
- in-vitro, Ovarian, CaOV3 - in-vitro, Nor, WRL68
selectivity↑, TumCP↓, MMP↓, Bcl-2↓, BAX↑, ROS↑,
2124- TQ,    Thymoquinone: an emerging natural drug with a wide range of medical applications
- Review, Var, NA
hepatoP↑, Bax:Bcl2↑, cycD1/CCND1↓, P21↑, TRAIL↑, P53↑, TumCCA↑, hepatoP↑, *ALAT↓, *AST↓, *MDA↓, *GSSG↓, *COX2/PTGS2↓, *lipid-P↓, PPARγ↑, p38↑, ROS↑, ChemoSen↑, selectivity↑, selectivity↑, *MDA↓, *SOD↑, *antiAll↑,
2084- TQ,    Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
- Review, Var, NA
*ROS↓, *chemoPv↑, ROS↑, ROS⇅, MUC4↓, selectivity↑, AR↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, survivin↓, Mcl-1↓, VEGF↓, cl‑PARP↑, ROS↑, HSP70/HSPA5↑, P53↑, miR-34a↑, Rac1↓, TumCCA↑, NOTCH↓, NF-kB↓, IκB↓, p‑p65↓, IAP1↓, IAP2/BIRC3↑, XIAP↓, TNF-α↓, COX2/PTGS2↓, Inflam↓, α-tubulin↓, Twist↓, EMT↓, mTOR↓, PI3K↓, Akt↓, BioAv↓, ChemoSen↑, CompStab↑, PTEN↑, chemoPv↑, RadioS↑, *Half-Life↝, *BioAv↝,
2093- TQ,    Regulation of NF-κB Expression by Thymoquinone; A Role in Regulating Pro-Inflammatory Cytokines and Programmed Cell Death in Hepatic Cancer Cells
- in-vitro, Liver, HepG2 - in-vitro, Nor, NA
TumCD↑, selectivity↑, Casp3↑, DLC1↑, NF-kB↑, LDH↑, *toxicity↓,
2096- TQ,    Effect of total hydroalcholic extract of Nigella sativa and its n-hexane and ethyl acetate fractions on ACHN and GP-293 cell lines
- in-vitro, Nor, GP-293 - in-vitro, Kidney, ACHN
selectivity↑, eff↝,
2097- TQ,    Crude extract of Nigella sativa inhibits proliferation and induces apoptosis in human cervical carcinoma HeLa cells
- in-vitro, Cerv, HeLa
Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8↑, cl‑PARP↑, cMyc↓, hTERT/TERT↓, cycD1/CCND1↓, CDK4↓, P53↑, P21↑, TumCP↓, Apoptosis↓, selectivity↑,
2106- TQ,    Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy
- Review, Var, NA
Apoptosis↑, TumCCA↑, ROS↑, *Catalase↑, *SOD↑, *GR↑, *GSTA1↓, *GPx↑, *H2O2↓, *ROS↓, *lipid-P↓, *HO-1↑, p‑Akt↓, AMPKα↑, NK cell↑, selectivity↑, Dose↝, eff↑, GSH↓, eff↓, P53↑, p‑STAT3↓, PI3K↑, MAPK↑, GSK‐3β↑, ChemoSen↑, RadioS↑, BioAv↓, NRF2↑,
2110- TQ,    Nigella sativa seed oil suppresses cell proliferation and induces ROS dependent mitochondrial apoptosis through p53 pathway in hepatocellular carcinoma cells
- in-vitro, HCC, HepG2 - in-vitro, BC, MCF7 - in-vitro, Lung, A549 - in-vitro, Nor, HEK293
P53↑, lipid-P↑, GSH↓, ROS↑, MMP↓, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, tumCV↓, selectivity↑,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2/PTGS2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
3422- TQ,    Thymoquinone, as a Novel Therapeutic Candidate of Cancers
- Review, Var, NA
selectivity↑, P53↑, PTEN↑, NF-kB↓, PPARγ↓, cMyc↓, Casp↑, *BioAv↓, CompStab↝, Synergy↑, survivin↓, Bcl-xL↓, Bcl-2↓, Akt↓, BAX↑, cl‑PARP↑, CXCR4↓, MMP9↓, VEGFR2/KDR/Flk1↓, Ki-67↓, COX2/PTGS2↓, JAK2↓, cSrc↓, Apoptosis↑, p‑STAT3↓, cycD1/CCND1↓, Casp3↑, Casp7↑, Casp9↑, N-cadherin↓, Vim↓, Twist↓, E-cadherin↑, ChemoSen↑, Synergy↑, EMT↓, ROS↑, DNMT1↓, Synergy↑, EZH2↓, hepatoP↑, Zeb1↓, RadioS↑, HDAC↓, HDAC1↓, HDAC2↓, HDAC3↓, *NAD↑, *SIRT1↑, SIRT1↓, *Inflam↓, *CRP↓, *TNF-α↓, *IL6↓, *IL1β↓, *Synergy↑, *MDA↓, *NO↓, *GSH↑, *SOD↑, *Catalase↑, *GPx↑, PI3K↓, mTOR↓,
3424- TQ,    Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
- Review, Var, NA
DNMT1↓, HDAC1↓, TumCCA↑, ROS↑, Apoptosis↑, angioG↓, TumMeta↓, selectivity↑, BioAv↓, BioAv↓, HDAC1↓, HDAC4↓, UHRF1↓, selectivity↑, G9a↓,
3421- TQ,    Insights into the molecular interactions of thymoquinone with histone deacetylase: evaluation of the therapeutic intervention potential against breast cancer
- Analysis, Nor, NA - in-vivo, Nor, NA - in-vitro, BC, MCF7 - in-vitro, Nor, HaCaT
HDAC↓, P21↑, Maspin↑, BAX↑, B2M↓, TumCCA↑, selectivity↑, *toxicity↓, TumCMig↓, TumCP↓,
7404- Trip,    Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug
- in-vitro, BC, MCF7
tumCV↓, selectivity↑, DNAdam↑, ROS↑, *ROS∅, Dose↓, TumCG↓,
5020- UA,    Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway
- in-vitro, Ovarian, NA
tumCV↓, selectivity↑, BAX↑, Bcl-2↓, Apoptosis↑, ROS↑, TumCCA↑, Akt↓, PI3K↓,
4857- Uro,    Evaluation and comparison of the anti-proliferative and anti-metastatic effects of urolithin A and urolithin B against esophageal cancer cells: an in vitro and in silico study
- in-vitro, ESCC, KYSE-30
tumCV↓, selectivity↑, TumCCA↑, ROS↑, Bcl-2↓, BAX↑, P21↑, MMP2↓, MMP9↓,
4838- Uro,    The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention
- Review, Var, NA
BioAv↑, Inflam↓, IL6↓, IL1β↓, NOS2↓, p53 Wildtype↑, MDM2↑, Snail↓, E-cadherin↑, N-cadherin↓, Vim↓, NF-kB↓, mTOR↓, p‑Akt↓, selectivity↑, EMT↓,
4854- Uro,    Urolithins: Emerging natural compound targeting castration-resistant prostate cancer (CRPC)
- Review, Pca, NA
AR↓, ROS↓, Apoptosis↑, selectivity↑, Dose↑, MDA↓, SOD↑, GPx↑, ROS↑, Casp3↑, Casp9↑,
1888- VitB1/Thiamine,  DCA,    High Dose Vitamin B1 Reduces Proliferation in Cancer Cell Lines Analogous to Dichloroacetate
- in-vitro, PC, SK-N-BE - NA, PC, PANC1
p‑PDH↓, GlucoseCon↓, lactateProd↓, MMP↓, Casp3↑, eff↑, PDKs↓, selectivity↑, TumCG↓, Dose∅, MMP↓, ROS∅, toxicity↑, antiOx↑,
1215- VitC,  immuno,    Metabolomics reveals ascorbic acid inhibits ferroptosis in hepatocytes and boosts the effectiveness of anti-PD1 immunotherapy in hepatocellular carcinoma
- ex-vivo, HCC, NA - in-vivo, HCC, NA
other↓, *GPx4↑, *GSH↑, GPx4↓, GSH↓, selectivity↑,
1836- VitC,  VitK3,  Chemo,    Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib
- in-vitro, AML, NA
tumCV↓, selectivity↑, Apoptosis↑, eff↑, ChemoSen↑,
1819- VitC,  VitK3,    The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy
- Review, Var, NA
Dose?, TumCD↑, selectivity↑, H2O2↑, ROS↑, DNAdam↑,
3145- VitC,    Vitamin C inhibits the growth of colorectal cancer cell HCT116 and reverses the glucose‐induced oncogenic effect by downregulating the Warburg effect
- in-vitro, CRC, HCT116
Warburg↓, TumCG↓, Glycolysis↓, GlucoseCon↓, ATP↓, lactateProd↓, selectivity↑, GLUT1↓, PKM2↓, LDHA↓, mTOR↓,
3104- VitC,    Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations
- Review, Var, NA
*antiOx↑, *ROS↓, *DNAdam↓, ROS↑, TET1↑, CSCs↓, HIF-1↓, BioAv↑, selectivity↑,
3109- VitC,    Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2/HO-1 Pathway
- in-vitro, Lung, H1299
TumMeta↓, NRF2↑, HO-1↑, cl‑Casp3↑, cl‑Casp9↑, DNAdam↑, Apoptosis↑, other↑, selectivity↑,
3133- VitC,    Vitamin C supplementation had no side effect in non-cancer, but had anticancer properties in ovarian cancer cells
- in-vitro, Ovarian, NA
*SVCT-2↑, *GLUT1↓, SVCT-2↓, GLUT1↑, TumCP↓, CDK2↓, PARP↓, selectivity↑,
6894- VitC,  Rad,    Pharmacological Ascorbate as a Means of Sensitizing Cancer Cells to Radio-Chemotherapy While Protecting Normal Tissue
- Review, Var, NA
AntiTum↑, selectivity↑, H2O2↑, RadioS↑, radioP↑, ChemoSen↑, ROS↑, DNAdam↑,
2279- VitK2,    Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways
- in-vitro, Bladder, T24/HTB-9 - in-vitro, Bladder, J82 - in-vitro, Nor, HEK293 - in-vitro, Nor, L02 - in-vivo, NA, NA
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,

Showing Research Papers: 651 to 700 of 706
Prev Page 14 of 15 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 706

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 4,   NA⇅, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 3,   antiOx↑, 17,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 8,   Catalase↑, 4,   ENOX2↓, 2,   Fenton↑, 8,   frataxin↑, 1,   GCLC↑, 1,   GPx↓, 2,   GPx↑, 2,   GPx4↓, 6,   GSH?, 1,   GSH↓, 46,   GSH↑, 5,   i-GSH∅, 1,   GSH/GSSG↓, 8,   GSSG↑, 3,   GSTs↑, 1,   GSTs↝, 1,   H2O2↓, 2,   H2O2↑, 14,   mt-H2O2↑, 1,   HO-1↓, 3,   HO-1↑, 11,   HO-2↓, 1,   Iron↓, 4,   Iron↑, 4,   i-Iron↓, 1,   Keap1↓, 2,   Keap1↑, 2,   Keap1↝, 1,   lipid-P↓, 2,   lipid-P↑, 20,   lipidDe↓, 1,   MDA↓, 3,   MDA↑, 7,   i-MDA↑, 1,   NADH↓, 3,   NADH↑, 1,   mt-NADH↓, 1,   NADHdeh?, 1,   NOX↓, 2,   NOX↑, 1,   NOX4↑, 1,   NQO1↓, 2,   NQO1↑, 2,   NRF2↓, 12,   NRF2↑, 14,   NRF2∅, 1,   p‑NRF2↑, 1,   Prx↓, 1,   Prx3↑, 1,   Prx4↓, 1,   Prx4↑, 1,   PrxI↓, 1,   RNS↑, 3,   ROS?, 6,   ROS↓, 25,   ROS↑, 326,   ROS⇅, 10,   ROS↝, 3,   ROS∅, 4,   i-ROS?, 1,   i-ROS↓, 1,   i-ROS↑, 4,   mt-ROS↑, 22,   RPM↑, 1,   SOD↓, 5,   SOD↑, 5,   SOD2↓, 3,   SOD2↑, 2,   Thiols↓, 3,   Trx↓, 4,   Trx↑, 2,   TrxR↓, 9,   TrxR↑, 1,   TrxR1↓, 2,   mt-TrxR1↓, 1,   xCT/SLC7A11↓, 4,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   IronCh↑, 1,   IronCh∅, 1,   STEAP3↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   p‑CDC2↓, 1,   CDC25↓, 8,   CDC25↑, 1,   compI↓, 9,   compII↓, 1,   compIII↓, 6,   compIII↑, 1,   compIV↓, 1,   compV↓, 1,   EGF↓, 2,   ETC↓, 11,   ETC↝, 1,   HSP60/HSPD1↑, 1,   Insulin↓, 3,   mitResp↓, 8,   mitResp↑, 1,   mitResp⇅, 1,   mtDam↑, 40,   OCR↓, 10,   OCR↑, 5,   OXPHOS↓, 10,   OXPHOS↑, 5,   mt-OXPHOS↓, 2,   mt-OXPHOS↑, 2,   PDH↑, 1,   p‑PDH↓, 2,   p‑PDH↑, 1,   PGC-1α↑, 2,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 4,   mt-TrxR2↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 1,   p‑ACC↑, 1,   ACLY↓, 1,   ALAT↓, 2,   AminoA↓, 1,   AMP↑, 1,   AMPK↑, 12,   p‑AMPK↑, 3,   ANXA7↑, 2,   ATP↓, 27,   ATP∅, 1,   ATP:AMP↓, 1,   cAMP↓, 1,   ECAR↓, 7,   ECAR↝, 1,   ECAR∅, 1,   FABP4↓, 1,   FAO↓, 1,   FAO↑, 1,   FASN↓, 1,   GAPDH↓, 2,   glucose↝, 1,   GlucoseCon↓, 16,   GlucoseCon∅, 1,   Glycolysis↓, 34,   Glycolysis∅, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 1,   H2S↑, 1,   Histones↝, 1,   HK2?, 1,   HK2↓, 11,   HK2∅, 1,   HMG-CoA↓, 5,   IDO1↓, 2,   KeyT↑, 1,   lactateProd↓, 21,   lactateProd↑, 1,   lactateProd∅, 1,   LDHA↓, 5,   LDHA∅, 1,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 2,   MCT4↓, 1,   NAD↓, 2,   NADPH↓, 4,   NADPH↑, 2,   OAA↑, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 9,   p‑PDK1 / PDPK1↓, 1,   PDKs↓, 6,   PDKs↑, 1,   PFK↓, 2,   PFK1↓, 2,   PFKP↓, 1,   PKM1↑, 1,   PKM2↓, 9,   polyA↓, 1,   PPP↑, 1,   Pyruv↓, 1,   SCD1↓, 4,   SIRT1↓, 4,   SIRT1↑, 2,   SREBP1/SREBF1↓, 1,   TCA?, 1,   TCA↓, 1,   TS↓, 2,   Warburg↓, 9,  

Cell Death(tgid=5) ⓘ

AIF↑, 18,   APAF1↑, 3,   Apoptosis?, 2,   Apoptosis↓, 11,   Apoptosis↑, 275,   Apoptosis∅, 1,   mt-Apoptosis↑, 4,   aSmase↑, 1,   BAD↓, 2,   BAD↑, 9,   Bak↑, 6,   BAX?, 1,   BAX↓, 2,   BAX↑, 97,   BAX⇅, 2,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 25,   Bcl-2?, 1,   Bcl-2↓, 102,   Bcl-2↑, 2,   Bcl-xL↓, 22,   BID↑, 4,   p‑BID↓, 1,   cl‑BID↑, 1,   BIM↑, 3,   BNIP3?, 1,   Casp↓, 2,   Casp↑, 39,   Casp↝, 1,   Casp1↑, 2,   Casp12↑, 2,   cl‑Casp12↑, 1,   Casp3?, 1,   Casp3↓, 4,   Casp3↑, 123,   cl‑Casp3↑, 31,   proCasp3↓, 1,   pro‑Casp3↓, 1,   pro‑Casp3↑, 1,   CASP4↑, 1,   Casp6↓, 1,   Casp6↑, 2,   Casp7↑, 21,   cl‑Casp7↑, 2,   Casp8↓, 2,   Casp8↑, 41,   cl‑Casp8↑, 3,   Casp9↓, 1,   Casp9↑, 79,   cl‑Casp9↑, 7,   pro‑Casp9↑, 1,   CellShr↑, 1,   cFLIP↓, 2,   Cupro↑, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 90,   Cyt‑c↝, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 4,   DR5↑, 13,   Endon↑, 2,   FADD↑, 2,   Fap1↓, 1,   Fas↓, 1,   Fas↑, 15,   FasL↑, 10,   Ferroptosis↑, 13,   GSDMC↑, 1,   GSDMD↑, 1,   IAP1↓, 2,   IAP1↑, 1,   IAP2/BIRC3↓, 2,   IAP2/BIRC3↑, 1,   ICAD↑, 1,   iNOS↓, 4,   Mcl-1↓, 10,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 6,   MDM2↑, 2,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↓, 2,   MOMP↑, 3,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 2,   p38↓, 3,   p38↑, 9,   p‑p38↓, 1,   p‑p38↑, 6,   Paraptosis↑, 5,   PUMA↑, 5,   Pyro↑, 5,   RIP3↑, 1,   p‑RIP3↑, 1,   SK↓, 1,   survivin↓, 28,   TNFR 1↑, 1,   TRAIL↑, 6,   TumCD↓, 2,   TumCD↑, 51,   TUNEL↑, 1,   XIAP↓, 15,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 81,   Akt↑, 4,   p‑Akt↓, 29,   p‑Akt↑, 1,   AKT1↓, 3,   AMPKα↑, 1,   CaMKII ↓, 1,   Cavin3↓, 1,   CIP2A↓, 1,   cSrc↓, 1,   EF-1α↓, 1,   EGFR↓, 15,   p‑EGFR↓, 1,   ERK↓, 26,   ERK↑, 6,   p‑ERK↓, 10,   p‑ERK↑, 5,   HER2/EBBR2↓, 3,   Hippo↑, 1,   IGF-1R↓, 1,   p‑IGF-1R↓, 1,   IKKα↓, 3,   IKKα↑, 1,   IκB↓, 1,   IκB↑, 1,   JAK↓, 3,   JAK1↓, 2,   JAK1↑, 1,   JAK2↓, 8,   JNK↓, 6,   JNK↑, 19,   p‑JNK↑, 7,   MAPK↓, 17,   MAPK↑, 10,   p‑MAPK↑, 2,   MARK4↓, 2,   MEK↓, 4,   MKP1↓, 1,   MKP2↓, 1,   mTOR↓, 40,   mTOR↑, 1,   mTOR⇅, 1,   p‑mTOR↓, 8,   mTORC2↑, 1,   p70S6↓, 1,   p‑P70S6K↓, 1,   P90RSK↓, 1,   PI3K↓, 51,   PI3K↑, 2,   p‑PI3K↓, 7,   PI3K/Akt↓, 1,   PIAS-3↑, 1,   PKA↓, 2,   PKCδ↓, 4,   PKCδ↑, 2,   PTEN↑, 14,   Raf↓, 3,   c-Raf↓, 1,   RAS↓, 4,   RIP1↓, 1,   p‑S6K↓, 2,   SHP1↑, 1,   Sp1/3/4↓, 9,   Src↓, 2,   p‑Src↓, 1,   STAT↓, 3,   STAT3↓, 36,   STAT3↑, 1,   p‑STAT3↓, 6,   p‑STAT3↑, 2,   mt-STAT3↓, 1,   STAT4↓, 1,   STAT6↓, 2,   p‑STK11/LKB1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↓, 1,   ATF3↑, 1,   ATF4↑, 6,   ATF4↝, 1,   BRD4↓, 1,   ChrMod↑, 2,   cJun↑, 3,   cMyc↓, 18,   cMyc↑, 1,   DNMT1↓, 6,   DNMT1↑, 1,   DNMTs↓, 6,   EZH2↓, 4,   FOXO↑, 2,   FOXO1↓, 1,   FOXO3↓, 2,   FOXO3↝, 1,   p‑FOXO3↓, 1,   FOXO4↑, 2,   GATA3↓, 1,   H3↑, 2,   ac‑H3↑, 4,   ac‑H3↝, 1,   H4↑, 1,   ac‑H4↓, 1,   ac‑H4↑, 4,   HATs↓, 3,   HATs↑, 2,   HDAC↓, 25,   HDAC1↓, 5,   HDAC2↓, 2,   HDAC3↓, 4,   HDAC4↓, 1,   HDAC6↓, 1,   HDAC8↓, 1,   HMTs↓, 1,   miR-124-3p↓, 1,   miR-148a↑, 1,   miR-203↑, 1,   miR-21↓, 2,   miR-34a↑, 1,   miR-375↑, 1,   Myc↓, 1,   n-MYC↓, 1,   OCT4↓, 4,   other?, 1,   other↓, 2,   other↑, 15,   other⇅, 1,   other↝, 22,   other∅, 1,   PhotoS↑, 1,   PRMT6↓, 1,   SETBP1↓, 1,   SOX2↓, 3,   SOX4↓, 1,   SOX4↑, 1,   SUV39H↓, 1,   SUZ12↓, 1,   tumCV?, 1,   tumCV↓, 117,   tumCV↑, 4,   UTF1↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 4,   CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 22,   cl‑CHOP/DDIT3↑, 1,   eIF2α↑, 2,   p‑eIF2α↓, 1,   p‑eIF2α↑, 2,   ER Stress↓, 1,   ER Stress↑, 40,   ERStress↑, 1,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 10,   GRP94↑, 1,   HSP27↑, 1,   HSP70/HSPA5↓, 2,   HSP70/HSPA5↑, 3,   HSP90↓, 7,   IRE1↑, 3,   PERK↓, 1,   PERK↑, 7,   p‑PERK↑, 1,   Proteasome?, 1,   Proteasome↓, 1,   UPR↑, 8,   XBP-1↓, 1,   XBP-1↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 6,   ATG7↑, 3,   Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 8,   CTSK↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3B↑, 2,   LC3B-II↓, 1,   LC3B-II↑, 2,   LC3I↑, 1,   LC3II↑, 9,   LC3s↓, 1,   lysoMP↑, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 6,   p‑p62↑, 1,   PARK2↑, 1,   SESN2↑, 1,   TumAuto?, 1,   TumAuto↓, 1,   TumAuto↑, 32,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   BRCA1↓, 1,   p‑BRCA1↑, 1,   BRCA2↓, 1,   DNA-PK↑, 2,   DNAdam↓, 1,   DNAdam↑, 96,   DNArepair↓, 3,   DNArepair↑, 1,   FEN1↓, 1,   G9a↓, 1,   hTERT/TERT↓, 5,   Ku70/XRCC6↓, 1,   MGMT↓, 1,   p16↑, 1,   P53↓, 2,   P53↑, 76,   P53↝, 3,   p‑P53↑, 3,   p53 Wildtype↓, 1,   p53 Wildtype↑, 1,   PARP↓, 9,   PARP↑, 13,   PARP↝, 1,   p‑PARP↑, 2,   cl‑PARP↓, 1,   cl‑PARP↑, 61,   PARP1↓, 1,   PARP1↑, 2,   cl‑PARP1↑, 3,   PCNA↓, 15,   PCNA↑, 1,   SIRT6↓, 1,   SIRT6↑, 1,   Telomerase↓, 8,   TOP1↓, 4,   TOP1↝, 1,   TOP2↓, 2,   TOP2↑, 2,   TP53↑, 1,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↑, 11,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↑, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 11,   CDK1↑, 1,   CDK2↓, 30,   CDK2↑, 1,   CDK4↓, 34,   CDK4↑, 1,   p‑CDK4↓, 1,   CDK6↓, 10,   CDK6↑, 3,   CDK8↓, 1,   CDKN1C/p57↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   cycA1/CCNA1↓, 6,   CycB/CCNB1↓, 18,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 50,   cycD1/CCND1↑, 1,   p‑cycD1/CCND1↓, 1,   CycD3↓, 1,   cycE/CCNE↓, 17,   cycE1↓, 2,   cycF↑, 1,   E2Fs↓, 2,   FBXO5/EMI1↓, 1,   GADD34↑, 1,   GADD45A↑, 2,   Ki-67↓, 14,   P21?, 1,   P21↓, 5,   P21↑, 51,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 22,   PLK1↓, 1,   pRB↓, 1,   pRB↑, 1,   p‑pRB↓, 2,   p‑RB1↓, 4,   TubPol↓, 1,   TumCCA?, 3,   TumCCA↓, 4,   TumCCA↑, 195,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   ALDH↓, 3,   ALDH1A1↓, 2,   ALDH1A3↓, 1,   BMI1↓, 1,   CD133↓, 3,   CD24↓, 4,   cFos↓, 1,   cFos↑, 1,   cMYB↓, 1,   CSCs↓, 39,   CSCs↑, 1,   Diff↓, 3,   Diff↑, 7,   EP4/PTGER4↓, 1,   HH↓, 2,   HH↝, 1,   HMGCR↓, 1,   HMGCR↑, 1,   IGF-1↓, 3,   IGFBP3↑, 1,   Ki-67↓, 14,   mTORC1↓, 1,   p‑mTORC1↓, 1,   Nanog↓, 3,   Nestin↓, 2,   NOTCH↓, 6,   NOTCH↑, 1,   NOTCH↝, 1,   NOTCH1↓, 5,   NOTCH2↑, 1,   NOTCH3↓, 2,   p300↓, 1,   SCF↓, 1,   Shh↓, 2,   STAT1↓, 1,   TOPflash↓, 1,   TumCG?, 1,   TumCG↓, 127,   TumCG↑, 4,   TumCG∅, 2,   TumCP?, 1,   TumCP↓, 148,   TumCP↑, 2,   Wnt↓, 23,   Wnt↝, 1,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   AP-1↓, 8,   ATPase↓, 1,   CA↓, 1,   Ca+2↓, 7,   Ca+2↑, 36,   Ca+2↝, 4,   i-Ca+2?, 1,   i-Ca+2↑, 2,   Cal1↑, 1,   cal2↑, 2,   Cal9↑, 1,   Cav1↑, 1,   CCN2/CTGF↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   i-Chl↑, 1,   Cofilin↓, 1,   p‑Cofilin↑, 1,   CTNNB1↓, 1,   DLC1↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 26,   EMT↓, 40,   EpCAM↓, 1,   F-actin↓, 2,   FAK↓, 5,   FAK↑, 1,   FAK↝, 1,   p‑FAK↓, 2,   fascin↓, 1,   Fibronectin↓, 2,   FOSB↑, 1,   ITGB1↓, 2,   ITGB3↓, 1,   ITGB6↓, 1,   KRAS↓, 1,   MALAT1↓, 2,   MET↑, 1,   MMP1↓, 1,   MMP2↓, 49,   MMP2↑, 1,   MMP3↓, 1,   MMP7↓, 2,   MMP9↓, 51,   MMPs↓, 11,   MUC4↓, 1,   N-cadherin?, 1,   N-cadherin↓, 12,   N-cadherin↑, 1,   PAK1↓, 2,   PDGF↓, 4,   Rac1↓, 2,   RECK↑, 2,   Rho↓, 3,   ROCK1↓, 1,   Slug↓, 4,   Smad1↑, 1,   p‑SMAD2↓, 1,   SMAD3↓, 1,   p‑SMAD3↓, 1,   Snail↓, 11,   TET1↑, 1,   TG2/TGase↓, 1,   TGF-β↓, 7,   TIMP1↓, 1,   TIMP1↑, 5,   TIMP2↑, 6,   TIMP3↑, 1,   TSC1↑, 1,   TumCA↑, 1,   TumCI?, 1,   TumCI↓, 63,   TumCMig?, 1,   TumCMig↓, 72,   TumMeta↓, 45,   TumMeta↑, 1,   Twist↓, 13,   uPA↓, 8,   uPAR↓, 1,   Vim↓, 13,   Zeb1↓, 8,   ZEB2↓, 1,   α-tubulin↓, 2,   β-catenin/ZEB1↓, 26,   β-catenin/ZEB1↑, 1,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 58,   angioG↑, 3,   CD31/PECAM-1↓, 2,   CD31/PECAM-1↑, 1,   EGR1↑, 1,   Endoglin↑, 3,   HIF-1↓, 6,   Hif1a↓, 33,   Hif1a↑, 2,   HIF2a↓, 1,   Hypoxia↓, 1,   LOX1↓, 1,   NO↓, 2,   NO↑, 7,   PHDs↓, 1,   VCAM-1↓, 3,   VEGF↓, 46,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 9,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 2,   CellMemb↑, 2,   CLDN1↓, 1,   CTR1↑, 1,   EPR↑, 10,   GLUT1↓, 8,   GLUT1↑, 1,   GLUT2↓, 2,   GLUT4↓, 1,   MMP?, 2,   MMP↓, 160,   MMP↝, 1,   MPT↓, 1,   MPT↑, 9,   NHE1↓, 2,   sonoP↑, 1,   SVCT-2↓, 1,   TRPC1↑, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 4,   TRPV2↑, 1,   VGCC↑, 1,   VGSC↑, 2,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

B2M↓, 1,   CCR7↓, 1,   CD4+↑, 1,   CD44↓, 10,   CD47↓, 1,   CD8+↑, 4,   cDC2↓, 1,   p‑cDC2↓, 1,   COX1↓, 2,   COX2/PTGS2↓, 34,   COX2/PTGS2↑, 4,   CXCc↓, 1,   CXCR4↓, 4,   DCells↑, 2,   DR4↑, 3,   DR6↑, 1,   FOXP3↓, 1,   HMGB1↓, 2,   ICAM-1↓, 5,   Igs↑, 1,   IL1↓, 2,   IL1↑, 1,   IL10↓, 1,   IL10↑, 1,   IL1β↓, 7,   IL1β↑, 3,   IL2↑, 1,   IL6↓, 16,   IL8↓, 4,   IL8↑, 1,   Imm↑, 11,   Imm↝, 1,   INF-γ↑, 1,   Inflam↓, 29,   LIF↑, 1,   M2 MC↓, 1,   MCP1/CCL2↓, 3,   MCT1↓, 1,   MIP-1β↑, 1,   NF-kB?, 1,   NF-kB↓, 76,   NF-kB↑, 9,   p‑NF-kB↑, 2,   NK cell↑, 8,   NLRP3↓, 1,   NLRP3↑, 3,   p50↓, 1,   p65↓, 3,   p‑p65↓, 1,   PD-L1↓, 3,   PGE2↓, 8,   PSA↓, 5,   RAGE↓, 1,   SOCS-3↓, 1,   SOCS-3↑, 1,   T-Cell↑, 2,   Th1 response↑, 1,   Th2↑, 1,   TLR4↓, 3,   TNF-α↓, 17,   TNF-α↑, 6,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   pH↑, 1,   pH↝, 2,   e-pH↑, 1,   i-pH↓, 1,   i-pH↑, 2,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   PSEN2/PS-2↓, 1,   p‑tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

6IL↑, 1,   AhR↑, 1,   AR↓, 11,   CYP24A1↓, 1,   ER-α36↓, 2,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   EstroRS/ERS↓, 1,   PPARα↓, 1,   PPARα↑, 1,   cl‑PPARα↓, 1,   PPARγ↓, 1,   PPARγ↑, 7,   SXR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   BioAv↓, 32,   BioAv↑, 38,   BioAv↝, 7,   BioEnh↑, 1,   chemoR↓, 2,   ChemoSen↓, 1,   ChemoSen↑, 161,   ChemoSen∅, 3,   CompStab↓, 1,   CompStab↑, 2,   CompStab↝, 1,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 2,   DDS↑, 1,   Dose?, 8,   Dose↓, 10,   Dose↑, 15,   Dose⇅, 1,   Dose↝, 84,   Dose∅, 18,   eff?, 1,   eff↓, 91,   eff↑, 143,   eff↝, 24,   GSTP1/GSTπ↓, 1,   GSTZ1↓, 1,   Half-Life?, 1,   Half-Life↓, 7,   Half-Life↑, 4,   Half-Life↝, 11,   Half-Life∅, 1,   MDR1↓, 2,   MRP1/ABCC1↓, 2,   MRP1/ABCC1↝, 1,   P-gp/ABCB1↓, 10,   P-gp/ABCB1∅, 1,   P450↓, 2,   P450↑, 1,   P450↝, 1,   RadioS↓, 1,   RadioS↑, 66,   selectivity?, 10,   selectivity↓, 10,   selectivity↑, 703,   selectivity↝, 3,   selectivity∅, 4,   Synergy↑, 103,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 2,   ALP↓, 1,   AR↓, 11,   AST↓, 1,   B2M↓, 1,   BG↓, 4,   BloodF↑, 1,   BMD↑, 1,   BRCA1↓, 1,   p‑BRCA1↑, 1,   CRP↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 15,   p‑EGFR↓, 1,   ERα/ESR1↓, 1,   EstroRS/ERS↓, 1,   EZH2↓, 4,   Ferritin↓, 1,   HER2/EBBR2↓, 3,   hTERT/TERT↓, 5,   IL6↓, 16,   KeyT↑, 1,   KRAS↓, 1,   LDH?, 1,   LDH↓, 6,   LDH↑, 6,   Maspin↑, 1,   Myc↓, 1,   NOS2↓, 2,   NOS2↑, 1,   PD-L1↓, 3,   Polyps↓, 1,   PSA↓, 5,   RAGE↓, 1,   SUZ12↓, 1,   TP53↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 57,   AntiCan∅, 1,   antiCG↓, 1,   AntiDiabetic↑, 1,   antiNeop↑, 1,   antiNeop∅, 1,   AntiTum↓, 1,   AntiTum↑, 24,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 1,   cardioP↑, 6,   CardioT↓, 1,   chemoP↑, 31,   chemoPv↑, 23,   ChemoSideEff↓, 3,   fatigue↓, 1,   hepatoP↑, 10,   hepatoP∅, 1,   neuroP↑, 8,   NP/CIPN↓, 1,   OS↑, 31,   OS⇅, 1,   OS∅, 1,   Pain↓, 4,   PDE4↓, 1,   PFS↑, 1,   QoL↑, 9,   radioP↑, 16,   Remission↑, 2,   RenoP↑, 4,   Risk↓, 16,   Risk↑, 1,   Sleep↑, 1,   Strength↑, 2,   toxicity↓, 31,   toxicity↑, 2,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 5,   TumVol↓, 38,   TumW↓, 18,   Weight↑, 4,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 4,   Bacteria↓, 6,   GutMicro↑, 3,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 7,  
Total Targets: 983

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 2,   antiOx↑, 71,   mt-antiOx↑, 1,   ARE↑, 1,   Catalase↑, 21,   Copper↓, 1,   Fenton↓, 2,   GPx↑, 19,   GPx1↑, 1,   GPx4↑, 1,   GSH↓, 1,   GSH↑, 19,   GSH/GSSG↑, 1,   GSR↑, 3,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 7,   H2O2↓, 1,   H2O2↑, 1,   HDL↓, 1,   HDL↑, 3,   HO-1↑, 13,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 1,   Iron∅, 1,   lipid-P↓, 15,   MDA↓, 13,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   Nrf1↑, 1,   NRF2↑, 21,   Prx↑, 1,   Prx4∅, 1,   RNS↓, 3,   ROS?, 2,   ROS↓, 64,   ROS↑, 4,   ROS∅, 18,   SAM-e↑, 1,   selenoP↑, 2,   SOD?, 1,   SOD↓, 1,   SOD↑, 23,   SOD1↑, 3,   SOD2↑, 2,   TAC↑, 1,   TBARS↓, 2,   VitC↑, 2,   VitE↓, 1,   VitE↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   EGF↓, 1,   mitResp↑, 1,   OCR↑, 1,   OXPHOS↑, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   ACLY∅, 1,   ALAT↓, 4,   AMPK↑, 1,   ATP↑, 4,   ATP↝, 1,   ECAR↓, 1,   GlucoseCon↑, 2,   Glycolysis↓, 2,   Glycolysis↑, 1,   GSK‐3β↓, 2,   HK2↓, 1,   HMG-CoA↓, 1,   lactateProd↓, 1,   LDL↓, 4,   lipidLev↓, 1,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 1,   NADPH↑, 1,   NADPH∅, 1,   PFK↓, 1,   SIRT1↑, 3,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   BAX↓, 1,   Bax:Bcl2↓, 1,   Bcl-2↑, 2,   Bcl-xL↑, 1,   Casp1↓, 1,   Casp12↓, 1,   Casp3↓, 3,   Casp3∅, 1,   cl‑Casp8↑, 1,   Casp9↓, 1,   Cyt‑c↓, 2,   Cyt‑c∅, 1,   Ferroptosis↓, 1,   GranB/GZMB↓, 1,   IAP1↓, 1,   iNOS↓, 5,   p38↓, 1,   survivin↓, 1,   TumCD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 2,   p‑Akt↓, 1,   ERK↓, 1,   ERK↑, 1,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   JAK2↑, 1,   JNK↓, 1,   JNK↑, 1,   p‑JNK↓, 1,   MAPK↓, 1,   mTOR↓, 4,   PI3K↑, 2,   PKCδ?, 1,   PTEN↑, 1,   STAT↓, 1,   STAT3↓, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 1,   other↓, 2,   other↑, 2,   other↝, 7,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 1,   p‑eIF2α↓, 1,   cl‑eIF2α↑, 1,   ER Stress↓, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 1,   HSP27↓, 1,   HSP70/HSPA5↓, 1,   p‑PERK↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 10,   DNAdam↑, 1,   P53↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cellSen↑, 1,   GADD45A↑, 1,   P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   Diff↑, 1,   EP2↓, 1,   FGF↑, 1,   neuroG↑, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   Ca+2↓, 4,   Ca+2↑, 1,   Ca+2↝, 2,   Ca+2∅, 1,   i-Ca+2↓, 1,   MMP13↓, 1,   MMP9↓, 1,   MMPs↑, 1,   PDGF↑, 1,   serineP↓, 1,   TGF-β↑, 2,   TIMP1↓, 1,   TumCI↓, 1,   TumCMig↓, 1,   α-tubulin↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 2,   NO↓, 4,   VCAM-1↓, 1,   VEGF↓, 1,   VEGF↑, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 6,   GastroP↑, 1,   GLUT1↓, 1,   IBI↑, 2,   MMP↑, 2,   MMP∅, 2,   SVCT-2↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX2/PTGS2↓, 10,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 3,   IL1↑, 1,   IL10↓, 1,   IL10↑, 2,   IL17↓, 2,   IL1β↓, 9,   IL23↓, 1,   IL4↓, 1,   IL4↑, 1,   IL6↓, 8,   IL8↓, 1,   Imm↑, 7,   Inflam↓, 63,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 3,   NF-kB↓, 14,   NLRP3↓, 2,   NLRP3↑, 1,   PGE2↓, 2,   PSA∅, 1,   TLR4↓, 1,   TNF-α↓, 11,   TNF-α↑, 1,   Treg lymp↝, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   AChE↓, 3,   AChE↑, 1,   BDNF↑, 5,   MAOA↓, 2,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 1,   Aβ↓, 7,   BACE/β-secretase↓, 1,   tau↓, 2,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

GR↑, 3,   PPARγ↑, 1,   testos↑, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 19,   BioAv↑, 21,   BioAv↝, 5,   BioEnh↑, 1,   CompStab↑, 2,   CompStab↝, 1,   Dose?, 1,   Dose↓, 1,   Dose↑, 2,   Dose↝, 14,   eff↑, 9,   eff↝, 1,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 3,   Half-Life∅, 2,   P450↓, 1,   selectivity↑, 13,   selectivity⇅, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 4,   ALP↓, 2,   AST↓, 4,   BG↓, 1,   BMD↑, 2,   BP↓, 4,   Calcium↑, 1,   creat↓, 2,   CRP↓, 3,   HbA1c↓, 1,   HOMA↓, 1,   hs-CRP↓, 2,   IL6↓, 8,   LDH↓, 1,   Mag↑, 1,   PSA∅, 1,   SpO2↑, 1,   TC↓, 1,   TG/TAG↓, 2,   Urea↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 5,   antiAll↑, 7,   AntiArt↑, 2,   AntiCan↓, 1,   AntiCan↑, 10,   AntiDiabetic↑, 10,   antiPs↑, 1,   AntiTum↓, 1,   AntiTum↑, 1,   cardioP↑, 16,   CardioT↓, 1,   chemoP↑, 12,   chemoPv↑, 3,   ChemoSideEff↓, 1,   cognitive↑, 5,   diuretic↑, 1,   hepatoP↑, 11,   memory↑, 8,   neuroP↑, 28,   Obesity↓, 4,   OS↑, 3,   Pain↓, 3,   radioP↑, 5,   RenoP↑, 3,   Risk↓, 2,   Sleep↑, 1,   Stress↓, 1,   Stroke↓, 2,   toxicity?, 2,   toxicity↓, 55,   toxicity↝, 11,   toxicity∅, 19,   Weight↑, 1,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiViral↑, 3,   Bacteria↓, 16,   GutMicro↑, 6,   Inf↓, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 3,  
Total Targets: 315

Scientific Paper Hit Count for: selectivity, selectivity
37 Silver-NanoParticles
30 Magnetic Fields
20 Radiotherapy/Radiation
17 Piperlongumine
14 Selenium NanoParticles
13 Phenethyl isothiocyanate
13 Thymoquinone
12 Chemotherapy
12 Betulinic acid
12 Sulforaphane (mainly Broccoli)
12 Dandelion Root
11 Magnetic Field Rotating
10 Vitamin C (Ascorbic Acid)
10 doxorubicin
10 Benzyl isothiocyanate
10 chitosan
10 Dichloroacetate
10 salinomycin
10 Fisetin
10 Shikonin
9 Capsaicin
9 Propolis -bee glue
9 Cisplatin
8 Carvacrol
8 Copper and Cu NanoParticles
8 Hydrogen Gas
8 Honokiol
8 Ivermectin
8 Magnolol
8 Quercetin
8 Selenite (Sodium)
7 Artemisinin
7 Berberine
7 Curcumin
7 Kaempferol
6 3-bromopyruvate
6 Fenbendazole
6 Apigenin (mainly Parsley)
6 Ashwagandha(Withaferin A)
6 Melatonin
6 Baicalein
6 Chrysin
6 Lemongrass Extract/Citral
6 EGCG (Epigallocatechin Gallate)
6 Gallic acid
6 HydroxyTyrosol
6 Linalool
5 Rosmarinic acid
5 Allyl isothiocyanate
5 Metformin
5 Boron
5 Selenium
5 Ellagic acid
5 Hibiscus sabdariffa
5 Indole-3-carbinol
5 Licochalcone A
5 Phycocyanin
4 Alpha-Lipoic-Acid
4 Phenylbutyrate
4 Gold NanoParticles
4 α-Bisabolol / Chamomile oil
4 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
4 chaetocin
4 diet FMD Fasting Mimicking Diet
4 diet Methionine-Restricted Diet
4 Eurycomanone
4 Eugenol
4 Graviola
4 phytic acid, Inositol hexakisphosphate
4 Lactoferrin/Talactoferrin
4 Luteolin
4 Lutein
4 Lycopene
4 mebendazole
4 Methyl Jasmonate
4 Morin
4 Parthenolide
4 α-Santalol/Sandalwood oil
4 Terpinen-4-ol / Tea Tree Oil
4 VitK3,menadione
3 1,8-Cineole
3 chemodynamic therapy
3 Allicin (mainly Garlic)
3 Astaxanthin
3 Atorvastatin
3 Isothiocyanates
3 Caffeic acid
3 Centella asiatica / Gotu kola → asiaticoside
3 Citric Acid
3 Coenzyme Q10
3 Cynaropicrin
3 Date Fruit Extract
3 Shilajit/Fulvic Acid
3 γ-linolenic acid (Borage Oil)
3 Helleborus niger extracts – Christmas Rose
3 Isobavachalcone
3 Isoliquiritigenin
3 isoorientin
3 isoquercitrin
3 Recombinant Methioninase
3 Nimbolide
3 Urolithin
2 Dipyridamole
2 Berbamine
2 Bifidobacterium
2 immunotherapy
2 Caffeic Acid Phenethyl Ester (CAPE)
2 Crocetin
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Hydroxycinnamic-acid
2 Dihydrocaffeic Acid
2 Chlorella (Chlorella vulgaris)
2 Docosahexaenoic Acid
2 Oxygen, Hyperbaric
2 D-limonene
2 Disulfiram
2 5-fluorouracil
2 Electrical Pulses
2 Evodiamine
2 Fucoidan
2 Gambogic Acid
2 Ginkgo biloba
2 Geldanamycin
2 Gossypol/AT-101
2 Hyperthermia
2 Hyperoside
2 Inositol
2 iodine
2 Juglone
2 Licorice
2 Methylene blue
2 methylseleninic acid
2 Methylglyoxal
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Marjoram (Origanum majorana)
2 SonoDynamic Therapy UltraSound
2 Plumbagin
2 Sulfasalazine
2 polyethylene glycol
2 Silymarin (Milk Thistle) silibinin
2 Aflavin-3,3′-digallate
2 Vitexin
2 Zerumbone
1 Açaí, Euterpe oleracea
1 Auranofin
1 Anzaroot, Astragalus fasciculifolius Bioss
1 Glucose
1 Ajoene (compound of Garlic)
1 Acetyl-l-carnitine
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Sorafenib (brand name Nexavar)
1 5-Aminolevulinic acid
1 Baicalin
1 Bufalin/Huachansu
1 probiotics
1 Brucea javanica
1 Brutieridin–Melitidin Mixture
1 Boswellia (frankincense)
1 Black Rice, Oryza sativa
1 Bullatacin
1 Butyrate
1 Carnosic acid
1 urea
1 Thymol-Thymus vulgaris
1 Cat’s Claw
1 Cannabidiol
1 Chocolate
1 Calorie Restriction Mimetics
1 Carvone
1 Polyphenols
1 Cucurbitacin
1 Cysteamine
1 Dichloroacetophenone(2,2-)
1 Deguelin
1 Diclofenac
1 diet Ketogenic
1 Docetaxel
1 Dimethyl Sulfoxide
1 Mistletoe/Viscum album Extracts
1 Echinacea
1 Ginkgo biloba-EGb 761
1 PXD, phenoxodiol
1 Emodin
1 Fennel Oil/Foeniculum vulgare
1 ferumoxytol
1 Formononetin
1 Flaxseed/Linseed
1 Flaxseed Oil
1 olaparib/LYNPARZA
1 Garcinol
1 Ginkgolic acids
1 Genistein (soy isoflavone)
1 Geraniol
1 Ginkgetin
1 Ginseng
1 Grapeseed extract
1 High-Ozonide Oil
1 Paclitaxel/Taxol
1 Gemcitabine (Gemzar)
1 Isorhamnetin
1 isoflavones
1 Isovitexin
1 Lactobacillus
1 lambertianic acid
1 low dose naltrexone
1 Photodynamic Therapy
1 Matrine
1 Mung Bean Sprouts
1 Lemon Balm/Melissa officinalis
1 Moringa oleifera
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Maitake
1 Bicarbonate(Sodium)
1 Oleuropein
1 Patchouli Oil (Pogostemon cablin)
1 Propyl gallate
1 temozolomide
1 borneol
1 Psoralidin
1 Pterostilbene
1 Resveratrol
1 irinotecan
1 Sesamin
1 Lignans
1 triptolide
1 Ursolic acid
1 Vitamin B1/Thiamine
1 Vitamin K2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1110  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page